• Molecular NameRosoxacin
  • SynonymAcrosoxacin; ROS; Rosoxacine [INN-French]; Rosoxacino [INN-Spanish]
  • Weight294.31
  • Drugbank_IDDB00817
  • ACS_NO40034-42-2
  • Show 2D model
  • LogP (experiment)2.23
  • LogP (predicted, AB/LogP v2.0)1.89
  • pkaN/A
  • LogD (pH=7, predicted)0.85
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-2.39
  • LogSw (predicted, AB/LogsW2.0)0.1
  • Sw (mg/ml) (predicted, ACD/Labs)0.05
  • No.of HBond Donors1
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds3
  • TPSA70.5
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA quinolone antibiotic indicated for the treatment of urinary tract infections and certain sexually transmitted diseases.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding81.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A